Kerri Aronson is a Respiratory physician affiliated with Cornell University. OpenAlex indexes 55 publications with 403 citations (h-index 10); ClinicalTrials.gov lists 2 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
425 E 61st St Fl 4
New York, NY 100658722
Telephone
646-962-2333Registry record last updated 9 Sept 2019.
Clinical trials
- Reimagining Interventions for Support and Education in Hypersensitivity Pneumonitis
Sponsor: Weill Medical College of Cornell University
- Assessing Health Related Quality of Life in Hypersensitivity Pneumonitis
Sponsor: Weill Medical College of Cornell University
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Boehringer Ingelheim Pharmaceuticals, Inc.Program year20252 payments
- Boehringer Ingelheim Pharmaceuticals, Inc.Program year20241 payment
- Boehringer Ingelheim Pharmaceuticals, Inc.Program year20231 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Respiratory
52%beta2-Adrenergic Agonist27.4%Albuterol Sulfate Hfa100%Part D≥16 patientsCorticosteroid24.6%Fluticasone Propionate41%Arnuity Ellipta30%Breo Ellipta30%Part D<11 patientsCancer & immunology
31.8%Kinase inhibitor31.8%Ofev100%Part D<11 patientsMetabolism & gastrointestinal
16.2%Corticosteroid16.2%Prednisone100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 2022–2025 per NIH RePORTER. The latest:
- Rise-HP: Reimagining Interventions for Support and Education in Hypersensitivity Pneumonitis; A Stakeholder Engaged Intervention to Improve Health-Related Quality of Life
Weill Medical Coll of Cornell Univ
FY2025$173,237K23HL163394 - Rise-HP: Reimagining Interventions for Support and Education in Hypersensitivity Pneumonitis; A Stakeholder Engaged Intervention to Improve Health-Related Quality of Life
Weill Medical Coll of Cornell Univ
FY2024$173,237K23HL163394 - Rise-HP: Reimagining Interventions for Support and Education in Hypersensitivity Pneumonitis; A Stakeholder Engaged Intervention to Improve Health-Related Quality of Life
Weill Medical Coll of Cornell Univ
FY2024$75,600K23HL163394
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Clinical utility of lung biopsy in fibrotic interstitial lung disease
American Journal of Respiratory and Critical Care Medicine
2026 - Management of interstitial lung disease in systemic autoimmune rheumatic diseases: a survey of rheumatologists and pulmonologists
Rheumatology Advances in Practice
2026 - Breath as a biomarker: harnessing volatile clues in interstitial lung disease diagnosis
American Journal of Respiratory and Critical Care Medicine
2026 - Higher BMI is associated with greater fatigue and dyspnea in interstitial lung disease: a Pulmonary Fibrosis Foundation Registry study
Annals of the American Thoracic Society
2026
Similar KOLs
Other experts from the same institution or the same specialty.
Richard Devereux, MD
Cornell University
Thomas Walsh, MD
Cornell University
Cora Sternberg, MD
Cornell University
George Alexopoulos, MD
Cornell University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”